| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.4 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |